» Articles » PMID: 31891082

Mechanistic Insights into the Effect of Ligands on Structural Stability and Selectivity of Sulfotransferase 2A1 (SULT2A1)

Overview
Journal ACS Omega
Specialty Chemistry
Date 2020 Jan 1
PMID 31891082
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cytosolic sulfotransferases (SULTs) acting as phase II metabolic enzymes can be used in the sulfonation of small molecules by transferring a sulfonate group from the unique co-factor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the substrates. In the present study, molecular dynamics (MD) simulations and ensemble docking study were employed to theoretically characterize the mechanism for the effect of co-factor (PAP) and ligands (LCA, raloxifene, α-hydroxytamoxifen, ouabain, and 3'-phosphoadenylyl sulfate) on structural stability and selectivity of SULT2A1 from the perspective of the dynamic behavior of SULT2A1 structures. Structural stability and network analyses indicated that the cooperation between PAP and LCA may enhance the thermal stability and compact communication in enzymes. During the MD simulations, the obviously rigid region and inward displacement were detected in the active-site cap (loop16) of the conformation containing PAP, which may be responsible for the significant changes in substrate accessibility and catalytic activity. The smaller substrates such as LCA could bind stably to the active pocket in the presence of PAP. However, the substrates or inhibitors with a large spatial structure needed to bind to the open conformation (without PAP) prior to PAPS binding.

Citing Articles

Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.

Toth D, Dudas B, Miteva M, Balog E Int J Mol Sci. 2023; 24(23).

PMID: 38069221 PMC: 10706399. DOI: 10.3390/ijms242316900.


Inhibition of Human Sulfotransferases by Phthalate Monoesters.

Huang H, Lan B, Zhang Y, Fan X, Hu M, Qin G Front Endocrinol (Lausanne). 2022; 13:868105.

PMID: 35528018 PMC: 9072656. DOI: 10.3389/fendo.2022.868105.


Binding Specificity of ASHH2 CW Domain Toward H3K4me1 Ligand Is Coupled to Its Structural Stability Through Its α1-Helix.

Brilkov M, Dobrovolska O, Odegard-Fougner O, Turcu D, Stromland O, Underhaug J Front Mol Biosci. 2022; 9:763750.

PMID: 35495628 PMC: 9043364. DOI: 10.3389/fmolb.2022.763750.


From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function.

Pedersen L, Yi M, Pedersen L, Kaminski A Drug Metab Dispos. 2022; 50(7):1027-1041.

PMID: 35197313 PMC: 10753775. DOI: 10.1124/dmd.121.000478.


Computational Analysis of Chemical Space of Natural Compounds Interacting with Sulfotransferases.

Lessigiarska I, Peng Y, Tsakovska I, Alov P, Lagarde N, Jereva D Molecules. 2021; 26(21).

PMID: 34770768 PMC: 8588419. DOI: 10.3390/molecules26216360.


References
1.
Negishi M, Pedersen L, Petrotchenko E, Shevtsov S, Gorokhov A, Kakuta Y . Structure and function of sulfotransferases. Arch Biochem Biophys. 2001; 390(2):149-57. DOI: 10.1006/abbi.2001.2368. View

2.
Skjaerven L, Yao X, Scarabelli G, Grant B . Integrating protein structural dynamics and evolutionary analysis with Bio3D. BMC Bioinformatics. 2014; 15:399. PMC: 4279791. DOI: 10.1186/s12859-014-0399-6. View

3.
Nicolai A, Delarue P, Senet P . Decipher the mechanisms of protein conformational changes induced by nucleotide binding through free-energy landscape analysis: ATP binding to Hsp70. PLoS Comput Biol. 2013; 9(12):e1003379. PMC: 3861046. DOI: 10.1371/journal.pcbi.1003379. View

4.
Pedersen L, Petrotchenko E, Negishi M . Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase. FEBS Lett. 2000; 475(1):61-4. DOI: 10.1016/s0014-5793(00)01479-4. View

5.
Bamforth K, Dalgliesh K, Coughtrie M . Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity?. Eur J Pharmacol. 1992; 228(1):15-21. DOI: 10.1016/0926-6917(92)90006-x. View